Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 490-499, 2004. First published January 15, 2004; 10.1373/clinchem.2003.026849
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
clinchem.2003.026849v1
50/3/490    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (50)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hafner, C.
Right arrow Articles by Vogt, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hafner, C.
Right arrow Articles by Vogt, T.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2004;50:490-499.)
© 2004 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers

Christian Hafner1, Gerd Schmitz2, Stefanie Meyer1, Frauke Bataille3, Peter Hau4, Thomas Langmann2, Wolfgang Dietmaier3, Michael Landthaler1 and Thomas Vogt1,a

1 Department of Dermatology, 2 Institute for Clinical Chemistry, 3 Institute of Pathology, and 4 Department of Neurology, University of Regensburg, Regensburg, Germany.

aAddress correspondence to this author at: Department of Dermatology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93042 Regensburg, Germany. Fax 49-941-944-9608; e-mail thomas.vogt{at}klinik.uni-regensburg.de.

Background: Eph receptors and their ligands, the ephrins, represent a large class of cell–cell communication molecules with well-defined developmental functions. Their role in healthy adult tissues and in human disease is still largely unknown, although diverse roles in carcinogenesis have been postulated.

Methods: We established a set of fluorescent PCR probes and primers for the definition of individual gene expression profiles of 12 different Eph receptors and 8 ephrins in 13 different healthy tissues. The mRNA expression profiles were studied in human lung, colorectal, kidney, liver, and brain cancers.

Results: The family of Eph receptors/ephrins was widely expressed in adult tissues with organ-site-specific patterns: EphB6 was highest in the thymus, compatible with an involvement in T-cell maturation. Brain and testis shared a unique pattern with EphA6, EphA8, and EphB1 being the most prominent. EphA7 had a high abundance in the kidney vasculature. Ephrin-A3 was up-regulated 26-fold in lung cancer, and EphB2 was up-regulated 9-fold in hepatocellular carcinoma. EphA8 was down-regulated in colon cancer, and EphA1/EphA8 was down-regulated in glioblastomas.

Conclusion: Eph/Ephrin genes are widely expressed in all adult organs with certain organ-site-specific patterns. Because their function in adult tissues remains unknown, further analysis of their role in disease may disclose new insights beyond their well-defined meaning in development.




The following articles in journals at HighWire Press have cited this article:


Home page
Vet PatholHome page
F. J. Torres-Velez, W. -J. Shieh, P. E. Rollin, T. Morken, C. Brown, T. G. Ksiazek, and S. R. Zaki
Histopathologic and Immunohistochemical Characterization of Nipah Virus Infection in the Guinea Pig
Vet. Pathol., July 1, 2008; 45(4): 576 - 585.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Wykosky, D. M. Gibo, and W. Debinski
A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells
Mol. Cancer Ther., December 1, 2007; 6(12): 3208 - 3218.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
K. B. Pabbisetty, X. Yue, C. Li, J.-P. Himanen, R. Zhou, D. B. Nikolov, and L. Hu
Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph receptors: Correlation to function in a growth cone collapse assay
Protein Sci., March 1, 2007; 16(3): 355 - 361.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. B. Larsen, M. W. Pedersen, M.-T. Stockhausen, M. V. Grandal, B. v. Deurs, and H. S. Poulsen
Activation of the EGFR Gene Target EphA2 Inhibits Epidermal Growth Factor-Induced Cancer Cell Motility
Mol. Cancer Res., March 1, 2007; 5(3): 283 - 293.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. K. Jassen, H. Yang, G. M. Miller, E. Calder, and B. K. Madras
Receptor Regulation of Gene Expression of Axon Guidance Molecules: Implications for Adaptation
Mol. Pharmacol., July 1, 2006; 70(1): 71 - 77.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Korff, G. Dandekar, D. Pfaff, T. Fuller, W. Goettsch, H. Morawietz, F. Schaffner, and H. G. Augustin
Endothelial EphrinB2 Is Controlled by Microenvironmental Determinants and Associates Context-Dependently With CD31
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 468 - 474.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. I. Bonaparte, A. S. Dimitrov, K. N. Bossart, G. Crameri, B. A. Mungall, K. A. Bishop, V. Choudhry, D. S. Dimitrov, L.-F. Wang, B. T. Eaton, et al.
From The Cover: Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
PNAS, July 26, 2005; 102(30): 10652 - 10657.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Liu, C. Stadelmann, M. Moscarello, W. Bruck, A. Sobel, F. G. Mastronardi, and P. Casaccia-Bonnefil
Expression of Stathmin, a Developmentally Controlled Cytoskeleton-Regulating Molecule, in Demyelinating Disorders
J. Neurosci., January 19, 2005; 25(3): 737 - 747.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Tamimi, M. Lines, M. Coca-Prados, and M. A. Walter
Identification of Target Genes Regulated by FOXC1 Using Nickel Agarose-Based Chromatin Enrichment
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3904 - 3913.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. van Doorn, R. Dijkman, M. H. Vermeer, J. J. Out-Luiting, E. M. H. van der Raaij-Helmer, R. Willemze, and C. P. Tensen
Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sezary Syndrome Identified by Gene Expression Analysis
Cancer Res., August 15, 2004; 64(16): 5578 - 5586.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.